AGIOS PHARMACEUTICALS, INC.

• CAMBRIDGE, MA How do I update this listing?

Agios Pharmaceuticals is based out of Cambridge. Agios Pharmaceuticals Inc is engaged in the development of medicines to treat the cancer metabolism and inborn errors of metabolism, which are a subset of orphan genetic metabolic diseases.Whalewisdom has at least 259 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2011-11-22. The notice included securities offered of Equity

Contact Info

agios pharmaceuticals, inc.
88 SIDNEY STREET
CAMBRIDGE MA 02139
Business Phone: 617-649-8600

SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Recent SEC Filings

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date	Form Type	Industry Group	Securities Offered	Total Offering Amount	Total Amount Sold	Total Remaining
2011-11-22	D	PHARMACEUTICALS	Equity	78,000,001	78,000,001	0
2010-04-26	D	PHARMACEUTICALS	Equity	8,823,937	8,823,937	0

Other Issuers in Filings
Name	Address
No Other Issuers

Related Parties included in filings
Name	Address	Relationship
DAVID SCHENKEIN	subscription required	EXECUTIVE OFFICER
DOUG COLE	subscription required	DIRECTOR
DUNCAN HIGGONS	subscription required	EXECUTIVE OFFICER
JOHN MARAGANORE	subscription required	DIRECTOR
KEVIN STARR	subscription required	DIRECTOR
LEWIS C. CANTLEY	subscription required	DIRECTOR
MARC TESSIER-LAVIGNE	subscription required	DIRECTOR
PERRY KARSEN	subscription required	DIRECTOR
ROBERT NELSEN	subscription required	DIRECTOR